cisplatin, gemcitabine

DRUG3 trials

Sponsors

Sun Yat-sen University, Hannover Medical School, Hospital do Coracao

Conditions

Cervical CancerCervix CancerCervix NeoplasmCholangiocarcinomasEfficacyNon-small Cell Lung Cancer

Phase 2

Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer

CompletedNCT01194453

Sun Yat-sen UniversityEfficacy, Non-small Cell Lung Cancer

Start: 2009-11-30End: 2012-08-31Updated: 2016-06-16

PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)

CompletedNCT01320254

Hannover Medical SchoolCholangiocarcinomas

Start: 2011-06-30End: 2016-09-12Updated: 2017-10-12

Phase 3

Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer

RecruitingNCT05764044

Hospital do CoracaoCervical Cancer, Cervix Cancer, Cervix Neoplasm

Start: 2024-03-27End: 2026-12-31Target: 365Updated: 2024-07-30

Related Papers

PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study.

2018-02-0351 citations

Panitumumab in combination with gemcitabine/cisplatin (GemCis) for patients with advanced kRAS WT biliary tract cancer: A randomized phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Journal of Clinical Oncology2015-05-2013 citations